HOME >> MEDICINE >> NEWS
Crohn's & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases

Global publisher John Wiley & Sons, Inc., announced today that it has been selected by the Crohn's & Colitis Foundation of America (CCFA) as the new publisher of the Foundation's official journal, Inflammatory Bowel Diseases, effective January 2007.

Inflammatory Bowel Diseases is the first and only peer-reviewed journal dedicated exclusively to inflammatory bowel diseases. Now in its tenth year, the journal provides articles of interest to professionals treating patients and conducting research in this expanding field. Each issue contains articles on clinical and basic science, as well as reviews of treatments and ground-breaking research.

"This is a wonderful partnership opportunity for Wiley," said Shawn Morton, Wiley Vice President and Publishing Director, Medicine. "We look forward to facilitating communication about the mechanisms and treatment of Crohn's disease and ulcerative colitis through this premier publication in collaboration with CCFA."

Wiley will begin publishing the journal in 2007 and will continue to make it available in print and online as a benefit of CCFA Professional Membership, and through subscription to other individual and institutional customers. Inflammatory Bowel Diseases will be available online via Wiley InterScience (www.interscience.wiley.com), the company's online publishing platform.

"CCFA is extremely proud of this journal, which provides an important forum for the best and the brightest scientists and clinicians in our field to report on the advances that are being made," said Jonathan Braun, M.D., Ph.D., Professor, David Geffen School of Medicine, UCLA Medical Center, and Chair of CCFA's National Scientific Advisory Committee. "We're confident that our partnership with Wiley will allow us to build on the journal's success, and expand our outreach to the medical community."


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
20-Mar-2006


Page: 1

Related medicine news :

1. ECP may be effective in treating Crohns disease
2. Smoking influences Crohns disease
3. Researchers identify new therapy for patients with Crohns disease
4. Canada high in ulcerative colitis and Crohns cases: Is Canada too clean?
5. Penn State research shows withdrawal drug offers relief for Crohns sufferers
6. Immune signals of variations of a single gene linked to more severe Crohns disease
7. Biologic therapies lead evolution of Crohns treatments
8. FDA grants priority review of Remicade® for children with Crohns disease
9. New insight into cause of Crohns disease
10. Improved diagnostic technology for Crohns disease
11. UVa Health System wins renewal of $6.2 million grant for Crohns disease research

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed ... consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has ... highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and ... financial results for the third quarter of 2017 on ... conference call on that day with the investment community ... The conference call will begin at 9 ... can access a live webcast of the conference call ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology:
Cached News: